Pegavision Corporation (6491.TW)

TWD 330.5

(1.85%)

Long Term Debt Summary of Pegavision Corporation

  • Pegavision Corporation's latest annual long term debt in 2023 was 365.09 Million TWD , down -38.74% from previous year.
  • Pegavision Corporation's latest quarterly long term debt in 2024 Q2 was 469.01 Million TWD , down -0.37% from previous quarter.
  • Pegavision Corporation reported annual long term debt of 595.98 Million TWD in 2022, up 137.35% from previous year.
  • Pegavision Corporation reported annual long term debt of 251.1 Million TWD in 2021, up 217.43% from previous year.
  • Pegavision Corporation reported quarterly long term debt of 515 Million TWD for 2024 Q3, up 9.81% from previous quarter.
  • Pegavision Corporation reported quarterly long term debt of 469.01 Million TWD for 2024 Q2, down -0.37% from previous quarter.

Annual Long Term Debt Chart of Pegavision Corporation (2023 - 2012)

Historical Annual Long Term Debt of Pegavision Corporation (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 365.09 Million TWD -38.74%
2022 595.98 Million TWD 137.35%
2021 251.1 Million TWD 217.43%
2020 79.1 Million TWD 36.05%
2019 58.14 Million TWD -88.07%
2018 487.5 Million TWD 951.21%
2017 46.37 Million TWD -59.67%
2016 115 Million TWD -34.19%
2015 174.75 Million TWD 1.92%
2014 171.45 Million TWD -14.95%
2013 201.59 Million TWD 17.58%
2012 171.45 Million TWD 0.0%

Peer Long Term Debt Comparison of Pegavision Corporation

Name Long Term Debt Long Term Debt Difference
Nang Kuang Pharmaceutical Co., Ltd. 12.56 Million TWD -2805.164%
Maxigen Biotech Inc. - TWD -Infinity%
SciVision Biotech Inc. 346.69 Million TWD -5.306%
Bionime Corporation 1.69 Billion TWD 78.49%
Visco Vision Inc. 848.86 Million TWD 56.991%